Tech Company Financing Transactions
Satellite Bio Funding Round
Satellite Bio closed a $110 million Series A financing round on 4/20/2022. Backers included aMoon Partners, Catalio Capital Management and Lightspeed Venture Partners.
Transaction Overview
Company Name
Announced On
4/20/2022
Transaction Type
Venture Equity
Amount
$110,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
610 Main Street
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Developer of a therapeutic platform designed to develop implantable organs for patients who suffer from serious diseases. The company's platform offers proprietary, off-the-shelf, implantable satellite organs as living therapeutic remedies, enabling patients to transform their lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dave Lennon
Chief Technical Officer
homas Lowery
Browse more venture capital transactions:
Prev: 4/20/2022: Vaayu venture capital transaction
Next: 4/20/2022: Bach venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs